Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABS) Exchange Rate Effect (2024 - 2025)

SAB Biotherapeutics (SABS) has disclosed Exchange Rate Effect for 2 consecutive years, with -$397861.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 37.79% year-over-year to -$397861.0, compared with a TTM value of -$213497.0 through Dec 2025, up 11.48%, and an annual FY2025 reading of -$213497.0, up 11.48% over the prior year.
  • Exchange Rate Effect was -$397861.0 for Q4 2025 at SAB Biotherapeutics, down from -$37537.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $179401.0 in Q2 2025 and bottomed at -$397861.0 in Q4 2025.